Inventor · disambiguated record
John P. Levy
Also filed as: LEVY JOHN P
8 granted patents·3 pending applications·44 citations·filing 1996–2022
84Inventor score
Files withGENVIVO INC5EPEIUS BIOTECHNOLOGIES CORP2HALL FREDERICK L2HUMAN GENE THERAPY RES INST1HUMAN GENE THERAPY RESEARCH IN1
Top patents by PatentIndex Score
11 records- 0187US10610603B2Thymidine kinase geneGENVIVO INC·Filed 2018·Granted Apr 7, 2020·2 cites·27 claims
- 0283US9925276B2Thymidine kinase geneEPEIUS BIOTECHNOLOGIES CORP·Filed 2014·Granted Mar 27, 2018·6 cites·36 claims
- 0379US2022401581A1Thymidine kinase geneGENVIVO INC·Filed 2022·Application pending·0 cites
- 0477US9999683B2Method for identifying and treating a patient having tumor lesions comprising administering a gene therapy retroviral vector particle comprising a mutated HSV-thymidine kinase (HSV-TK) polynucleotideEPEIUS BIOTECHNOLOGIES CORP·Filed 2014·Granted Jun 19, 2018·3 cites·24 claims
- 0576US10350302B2Thymidine kinase diagnostic assay for gene therapy applicationsGENVIVO INC·Filed 2018·Granted Jul 16, 2019·1 cites·30 claims
- 0673US11253611B2Thymidine kinase diagnostic assay for gene therapy applicationsGENVIVO INC·Filed 2019·Granted Feb 22, 2022·0 cites·38 claims
- 0772US11364307B2Thymidine kinase geneGENVIVO INC·Filed 2020·Granted Jun 21, 2022·0 cites·36 claims
- 0871US5869035AMethods and compositions for inducing complement destruction of tissueHUMAN GENE THERAPY RESEARCH IN·Filed 1996·Granted Feb 9, 1999·31 cites·14 claims
- 0950US2007178066A1Pathotropic targeted gene delivery system for cancer and other disordersHALL FREDERICK L·Filed 2006·Application pending·0 cites
- 1050US2009123428A1Pathotropic targeted gene delivery system for cancer and other disordersHALL FREDERICK L·Filed 2008·Application pending·0 cites
- 1133US6541197B2Vehicles for stable transfer of green fluorescent protein gene and methods of use for sameHUMAN GENE THERAPY RES INST·Filed 1997·Granted Apr 1, 2003·1 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when John P. Levy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →